Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Sep;68(9):1130-1153.
doi: 10.1590/1806-9282.2022D687.

Sugammadex in awakening from general anesthesia: systematic review and meta-analysis

Adriano Anzai  1 , Armelin Utino  1 , Giuliano Tosello  1 , Haroldo Katayama  1 , Ighor Alexander Zamuner Spir  1 , Luca Schiliró Tristão  1 , Mary Martins Nery  1 , Mauricio Anhesini  1 , Osvaldo Silvestrini Tiezzi  1 , Patricia Rodrigues Naufal Spir  1 , Pericles Otani  1 , Wanderley Marques Bernado  1
Affiliations
Meta-Analysis

Sugammadex in awakening from general anesthesia: systematic review and meta-analysis

Adriano Anzai et al. Rev Assoc Med Bras (1992). 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare there is no conflicts of interest.

Figures

Figure 1
Figure 1. Flowchart of selected studies.
Figure 2
Figure 2. Forest plot comparing sugammadex versus neostigmine in extubation time.
Figure 3
Figure 3. Forest plot comparing sugammadex versus neostigmine in neuromuscular block recovery time.
Figure 4
Figure 4. Forest plot comparing sugammadex versus neostigmine in time in the post-anesthesia care unit.
Figure 5
Figure 5. Forest plot comparing sugammadex versus neostigmine in evidence of bradycardia.
Figure 6
Figure 6. Forest plot comparing sugammadex versus neostigmine in evidence of hypertension.
Figure 7
Figure 7. Forest plot comparing sugammadex versus neostigmine in evidence of hypotension.
Figure 8
Figure 8. Forest plot comparing sugammadex versus neostigmine in evidence of hypoxemia.
Figure 9
Figure 9. Forest plot comparing sugammadex versus neostigmine in evidence of nausea.
Figure 10
Figure 10. Forest plot comparing sugammadex versus neostigmine in the outcome vomiting.
See this image and copyright information in PMC

References

    1. Tardelli MA. In: Curso de Educação à Distância em Anestesiologia. Sociedade Brasileira de Anestesiologia, editor. São Paulo: Office; 2002. Monitorização do Bloqueio Neuromuscular; pp. 177–190.
    1. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.
    1. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13–13. doi: 10.1186/1471-2288-5-13. - DOI - PMC - PubMed
    1. GRADEpro GDT . GRADEpro Guideline Development Tool [Software] Ontario: McMaster University; 2015.
    1. Quang TL, Thu HNT, Quoc KN, Thu HN, Van DP, Tien NLB, et al. Neuromuscular blockade agents reversal with sugammadex compared to neostigmine in the living kidney donors. Open Access Maced J Med Sci. 2019;7(24):4420–4425. doi: 10.3889/oamjms.2019.874. - DOI - PMC - PubMed